Position in LAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,710,773
+$945,687 QoQ
Shares Held
4,525,333
+50.6% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#10
of 143 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LAB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $200,471,862 across 21 Medical Devices names. LAB ranks #15 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESTA |
Establishment Labs Holdings Inc.
|
472,316 | $40,529,435 | |
| 2 | BVS |
Bioventus Inc.
|
1,833,212 | $17,305,521 | |
| 3 | APYX |
Apyx Medical Corp
|
3,274,064 | $14,700,547 | |
| 4 | AORT |
Artivion, Inc.
|
639,282 | $14,364,666 | |
| 5 | ENOV |
Enovis CORP
|
662,183 | $13,707,188 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
|
900,590 | $13,589,903 | |
| 7 | UFPT |
Ufp Technologies Inc
|
44,465 | $11,789,005 | |
| 8 | CBLL |
Ceribell, Inc.
|
605,010 | $11,767,444 |
All Filings in LAB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,710,773 | 4,525,333 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,765,086 | 3,005,529 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,693,477 | 2,885,529 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,646,134 | 2,804,719 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,164,545 | 2,637,121 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,160,543 | 2,000,503 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,547,130 | 1,455,503 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,186,085 | 614,552 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $538,488 | 304,231 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||